NCT02693223 Get With the Guidelines-Stroke Registry
| NCT ID | NCT02693223 |
| Status | Recruiting |
| Phase | — |
| Sponsor | American Heart Association |
| Condition | Stroke |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,892,063 participants |
| Start Date | 2003-01 |
| Primary Completion | 2040-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,892,063 participants in total. It began in 2003-01 with a primary completion date of 2040-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Get With The Guidelines-Stroke is a program for improving the quality of care for patients hospitalized with stroke by promoting consistent adherence to the latest evidence-based clinical practice guidelines.
Eligibility Criteria
Inclusion Criteria: * Patients presented with a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified to the hosptials. Exclusion Criteria: * Patients who do not have a diagnosis of Ischemic stroke or transient ischemic attack, Subarachnoid hemorrhage, Intracerebral hemorrhage, or Stroke not otherwise specified. * Patients under age of 18
Contact & Investigator
Javed Butler, MD
STUDY DIRECTOR
American Heart Association
Frequently Asked Questions
Who can join the NCT02693223 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 125 Years, studying Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02693223 currently recruiting?
Yes, NCT02693223 is actively recruiting participants. Contact the research team at amy.bennett@heart.org for enrollment information.
Where is the NCT02693223 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT02693223 clinical trial?
NCT02693223 is sponsored by American Heart Association. The principal investigator is Javed Butler, MD at American Heart Association. The trial plans to enroll 3,892,063 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.